Ajanta Pharma informs about disclosure

25 Feb 2022 Evaluate

Ajanta Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 25, 2022 for Ravi Agrawal,Trustee Ravi Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2850.00 -3.10 (-0.11%)
08-Jan-2026 11:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1769.10
Dr. Reddys Lab 1227.95
Cipla 1465.15
Zydus Lifesciences 925.95
Lupin 2191.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×